Annual Short Term Debt
$334.00 K
-$4.68 M-93.34%
31 December 2023
Summary:
Kala Pharmaceuticals annual short term debt is currently $334.00 thousand, with the most recent change of -$4.68 million (-93.34%) on 31 December 2023. During the last 3 years, it has fallen by -$1.20 million (-78.17%). KALA annual short term debt is now -95.27% below its all-time high of $7.06 million, reached on 31 December 2017.KALA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$18.34 M
+$6.00 M+48.65%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly short term debt is currently $18.34 million, with the most recent change of +$6.00 million (+48.65%) on 30 September 2024. Over the past year, it has increased by +$18.02 million (+5562.04%). KALA quarterly short term debt is now at all-time high.KALA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -93.3% | +5562.0% |
3 y3 years | -78.2% | +873.2% |
5 y5 years | -27.9% | +1334.3% |
KALA Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -93.3% | at low | at high | |
5 y | 5 years | -93.3% | at low | at high | |
alltime | all time | -95.3% | at low | at high |
Kala Pharmaceuticals Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $18.34 M(+48.7%) |
June 2024 | - | $12.34 M(+94.7%) |
Mar 2024 | - | $6.34 M(+1797.3%) |
Dec 2023 | $334.00 K(-93.3%) | $334.00 K(+3.1%) |
Sept 2023 | - | $324.00 K(>+9900.0%) |
June 2023 | - | $0.00(-100.0%) |
Mar 2023 | - | $3000.00(-99.9%) |
Dec 2022 | $5.01 M(+605.1%) | $5.01 M(>+9900.0%) |
Sept 2022 | - | $32.00 K(-38.5%) |
June 2022 | - | $52.00 K(-91.7%) |
Mar 2022 | - | $625.00 K(-12.1%) |
Dec 2021 | $711.00 K(-53.5%) | $711.00 K(-62.3%) |
Sept 2021 | - | $1.89 M(-4.7%) |
June 2021 | - | $1.98 M(-0.4%) |
Mar 2021 | - | $1.99 M(+29.7%) |
Dec 2020 | $1.53 M | $1.53 M(+3.6%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2020 | - | $1.48 M(+3.6%) |
June 2020 | - | $1.43 M(+3.6%) |
Mar 2020 | - | $1.38 M(+3.6%) |
Dec 2019 | $1.33 M(+186.6%) | $1.33 M(+3.8%) |
Sept 2019 | - | $1.28 M(-21.4%) |
June 2019 | - | $1.63 M(+0.4%) |
Mar 2019 | - | $1.62 M(+249.9%) |
Dec 2018 | $463.00 K(-93.4%) | $463.00 K(-86.5%) |
Sept 2018 | - | $3.43 M(+83.7%) |
June 2018 | - | $1.87 M(+523.0%) |
Mar 2018 | - | $300.00 K(-95.8%) |
Dec 2017 | $7.06 M(+1170.5%) | $7.06 M(+15.6%) |
Sept 2017 | - | $6.11 M(+175.0%) |
June 2017 | - | $2.22 M(+60.0%) |
Mar 2017 | - | $1.39 M(+149.8%) |
Dec 2016 | $556.00 K(-72.2%) | $556.00 K |
Dec 2015 | $2.00 M | - |
FAQ
- What is Kala Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual short term debt year-on-year change?
- What is Kala Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly short term debt year-on-year change?
What is Kala Pharmaceuticals annual short term debt?
The current annual short term debt of KALA is $334.00 K
What is the all time high annual short term debt for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual short term debt is $7.06 M
What is Kala Pharmaceuticals annual short term debt year-on-year change?
Over the past year, KALA annual short term debt has changed by -$4.68 M (-93.34%)
What is Kala Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of KALA is $18.34 M
What is the all time high quarterly short term debt for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly short term debt is $18.34 M
What is Kala Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, KALA quarterly short term debt has changed by +$18.02 M (+5562.04%)